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ABOUT THE COVER
To elucidate the potential mode of action ofMAP-based cytolytic fusion proteins in living cells,
colocalization assayswere performed using EGFRþA549 cells transfectedwith a SNAP-tagged
tubulin DNA construct. Expressed SNAP-tagged tubulin molecules were labeled with
SNAP-Cell TMR-Star (green). EGF-MAPf151 was used as a representative forMAP-based CFPs.
MAPf151 was detected using mouse–anti-human Tau and goat–anti-mouse Alexa Fluor 647
antibodies (red). DAPI was used to counterstain the nucleus (blue). Using confocal
fluorescence microscopy and a tubulin polymerization assay, it could be shown that MAP
colocalized with and stabilized microtubules. For more details, see article by Hristodorov and
colleagues on page 2194.
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